Conference Coverage: European Society for Medical Oncology (ESMO)

Conference Coverage

SOLAR-1 shines light on PI3K in breast cancer

MUNICH – The selective PI3K inhibitor added to fulvestrant extended progression-free survival in breast cancer patients with PIK3CA mutations.

Conference Coverage

Finally, immunotherapy shows benefit in TNBC

MUNICH – Adding atezolizumab to nab-paclitaxel improved progression-free and overall survival in patients with PD-L1 positive triple-negative...

Pages